Amrize Announces Date for Second Quarter 2025 Financial Results
Registration for the Q2 2025 live webcast can be completed at https://amrize-quarterly-results-q2-2025.open-exchange.net/
Amrize's financial results, presentation materials and webcast will be accessible in the events section of www.amrize.com/investors. A replay and transcript will be available at the same location following the webcast.
About Amrize
Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network, we deliver for our customers in every U.S. state and Canadian province. Our 19,000 teammates uniquely serve every construction market from infrastructure, commercial and residential to new build, repair and refurbishment. Amrize achieved $11.7 billion in revenue in 2024 and is listed on the New York Stock Exchange and the SIX Swiss Exchange. We are ready to build your ambition.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
11 minutes ago
- Global News
Saskatchewan's premier optimistic after talks at Council of Federation
See more sharing options Send this page to someone via email Share this item on Twitter Share this item via WhatsApp Share this item on Facebook New partnerships were made during the Council of Federation meeting, with Saskatchewan signing multiple memorandums of understanding with other provinces advocating for cross-Canada trade. Provincial affairs reporter Katherine Ludwig sat down with Premier Scott Moe in the video above to get his thoughts.
CTV News
11 minutes ago
- CTV News
UnitedHealth says it is under a U.S. federal investigation and co-operating
The logo for UnitedHealth Group appears above a trading post on the floor of the New York Stock Exchange, April 17, 2025. (AP Photo/Richard Drew) Shares of UnitedHealth Group slipped Thursday after the health care giant said it was under a U.S. Department of Justice investigation. The company said it has started complying with both criminal and civil requests from federal investigators and it was cooperating with them. '(UnitedHealth) has a long record of responsible conduct and effective compliance,' the company said in a Securities and Exchange Commission filing. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. The Journal said in February, citing anonymous sources, that the probe focused on billing practices in recent months. The paper then said earlier this month that a federal criminal health care-fraud unit was investigating how the company used doctors and nurses to gather diagnoses that bolster payments. UnitedHealth Group Inc. said that it reached out to the Justice Department 'after reviewing media reports about investigations into certain aspects of the company's participation in the Medicare program.' UnitedHealth runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. UnitedHealth raked in more than US$400 billion in revenue last year as the third-largest company in the Fortune 500. Last year, its share price topped $630 to reach a new all-time high. But company shares have mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. A 26-year-old suspect, Luigi Mangione, has been charged in connection with the shooting. In April, shares plunged after the company cut its forecast due to a spike in health care use. A month later, former CEO Andrew Witty resigned and the company withdrew its forecast. The stock price slipped another 2%, or $5.12, to $287.39 Thursday morning. That represents a 54% drop from its all-time high. UnitedHealth will report its second-quarter results next Tuesday. Tom Murphy, The Associated Press
CTV News
11 minutes ago
- CTV News
Keurig Dr Pepper quarterly revenue beats expectations fueled by U.S. demand
The logo for Keurig Dr. Pepper appears above a trading post on the floor of the New York Stock Exchange, Thursday, July 12, 2018. (AP Photo/Richard Drew, File) Keurig Dr Pepper reported second-quarter slightly revenue above Wall Street expectations on Thursday, driven by strong demand for its energy drinks and soft beverages, especially in the U.S. Why it is important The Snapple maker enjoyed resilient demand for its higher-priced ready-to-drink beverages, including Yoo-Hoo and Crush, and through the popularity of its majority-owned energy-drink maker, Ghost. The company's results mirror those of bigger rivals PepsiCo's and Coca-Cola's, both of which recently beat quarterly estimates on strong demand. Key quote 'Though the back half will present new challenges, we are on track to deliver our 2025 outlook,' said CEO Tim Cofer. Market reaction Shares of Keurig Dr Pepper, which rose about four per cent so far this year, were flat in premarket trading. Context Instability arising from U.S. President Donald Trump's fluctuating tariff policies and the resulting trade tensions has led to a decline in consumer spending. Keurig also faces a direct risk from tariffs on its business in Canada and Mexico, especially due to the Canadian boycott of U.S. products, and the impact of tariff-driven coffee prices. By the numbers Net sales for the quarter rose 6.1 per cent to US$4.16 billion, compared with estimates of US$4.14 billion, according to data compiled by LSEG. Keurig Dr Pepper posted an adjusted profit of 49 cents per share, in line with analysts' estimates. The Sun Drop maker's volumes grew five per cent compared to a 1.8 per cent rise a year ago, with Ghost contributing 4 percentage points to the volume growth. Net sales in the U.S. beverages segment rose 10.5 per cent compared to a 3.3 per cent rise in the year-ago quarter. The company continues to expect annual net sales to grow in the mid-single-digit range and adjusted profit to grow in the high-single digits. --- Reporting by Neil J Kanatt in Bengaluru; Editing by Shailesh Kuber
